Lanlan Lin

426 total citations
27 papers, 328 citations indexed

About

Lanlan Lin is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Lanlan Lin has authored 27 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Biomedical Engineering and 7 papers in Biomaterials. Recurrent topics in Lanlan Lin's work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Crystallization and Solubility Studies (5 papers). Lanlan Lin is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Crystallization and Solubility Studies (5 papers). Lanlan Lin collaborates with scholars based in China and United Kingdom. Lanlan Lin's co-authors include Junbo Gong, Peng Yang, Kangli Li, Songgu Wu, Guofu Lin, Shijie Xu, Yujia Qin, Shuang Jiang, Shichao Du and Luyang Chen and has published in prestigious journals such as Oncogene, Frontiers in Immunology and Journal of Materials Science.

In The Last Decade

Lanlan Lin

25 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanlan Lin China 11 172 78 72 64 58 27 328
Aipeng Li China 13 95 0.6× 2 0.0× 288 4.0× 22 0.3× 115 2.0× 25 430
Kenya Kimura Japan 12 114 0.7× 2 0.0× 119 1.7× 83 1.3× 18 0.3× 30 546
Toshiyuki Seki Japan 12 39 0.2× 4 0.1× 102 1.4× 23 0.4× 35 0.6× 34 386
Jeffrey W. Finch United States 10 23 0.1× 7 0.1× 207 2.9× 191 3.0× 48 0.8× 15 406
Yoko Imamura Japan 12 73 0.4× 2 0.0× 68 0.9× 27 0.4× 13 0.2× 20 324
Nannan Fan China 13 184 1.1× 179 2.5× 179 2.8× 164 2.8× 26 570
Fengli Zhang China 11 102 0.6× 205 2.8× 61 1.0× 100 1.7× 30 416
Francesco Bartoli Italy 11 48 0.3× 4 0.1× 82 1.1× 64 1.0× 30 0.5× 43 317

Countries citing papers authored by Lanlan Lin

Since Specialization
Citations

This map shows the geographic impact of Lanlan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Lin more than expected).

Fields of papers citing papers by Lanlan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Lin. The network helps show where Lanlan Lin may publish in the future.

Co-authorship network of co-authors of Lanlan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlan Lin. A scholar is included among the top collaborators of Lanlan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlan Lin. Lanlan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Lanlan, Luyang Chen, Guofu Lin, et al.. (2025). Derlin-3 manipulates the endoplasmic reticulum stress and IgG4 secretion of plasma cells in lung adenocarcinoma. Oncogene. 44(30). 2620–2633. 1 indexed citations
2.
Lin, Lanlan, et al.. (2025). Endoplasmic reticulum stress in lung cancer. Frontiers in Oncology. 15. 1550075–1550075.
3.
Lin, Guofu, Lanlan Lin, Xiaohong Chen, et al.. (2024). PPAR-γ/NF-kB/AQP3 axis in M2 macrophage orchestrates lung adenocarcinoma progression by upregulating IL-6. Cell Death and Disease. 15(7). 532–532. 11 indexed citations
4.
Yang, Dongyong, Lanlan Lin, Liying Yu, et al.. (2024). Important functions and molecular mechanisms of aquaporins family on respiratory diseases: potential translational values. Journal of Cancer. 15(18). 6073–6085. 3 indexed citations
5.
6.
Lin, Lanlan, et al.. (2023). FUT3 facilitates glucose metabolism of lung adenocarcinoma via activation of NF-κB pathway. BMC Pulmonary Medicine. 23(1). 436–436. 7 indexed citations
7.
Lin, Guofu, et al.. (2022). C1QTNF6 regulated by miR‐29a-3p promotes proliferation and migration in stage I lung adenocarcinoma. BMC Pulmonary Medicine. 22(1). 285–285. 8 indexed citations
8.
Lin, Guofu, Lanlan Lin, Jiefeng Huang, et al.. (2022). LncRNA XR_596701 protects H9c2 cells against intermittent hypoxia-induced injury through regulation of the miR-344b-5p/FAIM3 axis. Cell Death Discovery. 8(1). 42–42. 9 indexed citations
9.
Lin, Guofu, et al.. (2022). KCNK3 inhibits proliferation and glucose metabolism of lung adenocarcinoma via activation of AMPK-TXNIP pathway. Cell Death Discovery. 8(1). 360–360. 17 indexed citations
10.
Lin, Lanlan, Guofu Lin, Luyang Chen, et al.. (2022). Integrated profiling of endoplasmic reticulum stress-related DERL3 in the prognostic and immune features of lung adenocarcinoma. Frontiers in Immunology. 13. 906420–906420. 9 indexed citations
11.
Tao, Caihong, et al.. (2022). Construction of Mpda@Ir780 Nano Drug Carriers and Photothermal Therapy of Tumor Cells. SSRN Electronic Journal. 1 indexed citations
12.
Lin, Lanlan, et al.. (2022). Construction of MPDA@IR780 nano drug carriers and photothermal therapy of tumor cells. Journal of Drug Delivery Science and Technology. 76. 103819–103819. 2 indexed citations
13.
Lin, Lanlan, et al.. (2021). ARHGAP10 inhibits the epithelial–mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway. Cancer Cell International. 21(1). 320–320. 10 indexed citations
14.
Lin, Guofu, et al.. (2021). Comprehensive Analysis of Aquaporin Superfamily in Lung Adenocarcinoma. Frontiers in Molecular Biosciences. 8. 736367–736367. 14 indexed citations
15.
Lin, Lanlan, Guofu Lin, Fan Yang, & Xiangqi Chen. (2020). A systematic review and meta-analysis of immune-mediated liver dysfunction in non-small cell lung cancer. International Immunopharmacology. 83. 106537–106537. 10 indexed citations
16.
Lin, Lanlan, Guofu Lin, Qiong Luo, & Xiangqi Chen. (2019). The incidence and relative risk of PD-1/PD-L1 inhibitors-related colitis in non-small cell lung cancer: A meta-analysis of randomized controlled trials. International Immunopharmacology. 77. 105975–105975. 5 indexed citations
17.
Li, Kangli, Songgu Wu, Shijie Xu, et al.. (2016). Oiling out and Polymorphism Control of Pyraclostrobin in Cooling Crystallization. Industrial & Engineering Chemistry Research. 55(44). 11631–11637. 28 indexed citations
18.
Lin, Lanlan, Shichao Du, Cui Huang, et al.. (2016). Measurement and Correlation of Solubility of γ-Aminobutyric Acid in Different Binary Solvents. Journal of Chemical & Engineering Data. 61(3). 1210–1220. 19 indexed citations
19.
Lin, Lanlan, et al.. (2015). Measurement and Correlation of Solubility of Cefathiamidine in Water + (Acetone, Ethanol, or 2-Propanol) from (278.15 to 308.15) K. Journal of Chemical & Engineering Data. 61(1). 412–419. 12 indexed citations
20.
Chen, Mingyang, Lanlan Lin, Yuqi Zhang, et al.. (2015). Mechanism and inhibition of trisodium phosphate particle caking: Effect of particle shape and solubility. Particuology. 27. 115–121. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026